Fundz

Vascugen, Inc. reported raising $10 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEAug 24, 2020

Amount Raised

$10 Million

$10 Million sold, per SEC Form D (first sale Aug 24, 2020)

Round Type

Venture

MadisonBiotechnology

Quick answer

Vascugen, Inc. raised $10 Million in a funding round, dated August 24, 2020. Vascugen, Inc. is based in Madison, Wisconsin, United States.

How much did Vascugen, Inc. raise?
Vascugen, Inc. raised $10 Million in a funding round on August 24, 2020.
What does Vascugen, Inc. do?
Vascugen is a biotechnology company that is advancing a pipeline of regenerative medicines for treatment of intractable vascular diseases.
Where is Vascugen, Inc. based and how big is it?
Vascugen, Inc. is based in Madison, Wisconsin, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Vascugen, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • C19 Corp. raised $18M on October 8, 2020.
  • GeoVax Labs raised $1.5M on October 8, 2020.
  • Pictor Labs raised $617K (Seed) on October 7, 2020.
  • Koligo Therapeutics, Inc. raised $1.6M (Seed) on October 7, 2020.
  • Renata Medical raised $4.4M (Seed) on October 7, 2020.
  • Bright Minds Biosciences raised $218K (Pre-Seed) on October 7, 2020.

Who to call at Vascugen, Inc., and when

A new round usually means Vascugen, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vascugen, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vascugen, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vascugen, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vascugen, Inc.

Location

5602 RESEARCH PARK BLVD.

Madison, Wisconsin, United States

About

Vascugen is a biotechnology company that is advancing a pipeline of regenerative medicines for treatment of intractable vascular diseases. Our primary target indication is Critical Limb Ischemia (CLI), where new approaches are needed for millions of patients with this highly morbid condition.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vascugen, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Vascugen, Inc.'s next move

See what Strategic adds

Vascugen, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.